22 | IpilimumabIBA
10/2022
-
08/2010 |
13 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
-
01/2012 |
11 | NivolumabIBA
10/2022
-
08/2014 |
11 | VemurafenibIBA
01/2020
-
12/2011 |
11 | Interleukin-2 (IL2)IBA
01/2019
-
01/2002 |
9 | trametinibIBA
01/2020
-
08/2012 |
8 | Peptides (Polypeptides)IBA
02/2022
-
12/2011 |
7 | Type 1 Melanocortin ReceptorIBA
02/2022
-
11/2018 |
7 | Pharmaceutical PreparationsIBA
01/2019
-
04/2009 |
6 | LactamsIBA
01/2022
-
01/2019 |
6 | dabrafenibIBA
01/2018
-
11/2012 |
6 | Dacarbazine (DIC)FDA LinkGeneric
08/2014
-
05/2008 |
5 | alpha-MSHIBA
02/2022
-
01/2019 |
5 | AcidsIBA
02/2022
-
01/2020 |
5 | pembrolizumabIBA
12/2021
-
08/2014 |
5 | Immune Checkpoint InhibitorsIBA
01/2019
-
12/2016 |
5 | Proteins (Proteins, Gene)FDA Link
01/2018
-
01/2007 |
5 | Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2016
-
01/2005 |
5 | Imatinib Mesylate (Gleevec)FDA Link
05/2015
-
01/2007 |
5 | Monoclonal AntibodiesIBA
01/2014
-
03/2010 |
4 | triazacyclononaneIBA
01/2022
-
01/2020 |
4 | L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
-
06/2010 |
4 | CTLA-4 AntigenIBA
01/2019
-
08/2010 |
4 | AntibodiesIBA
08/2014
-
11/2008 |
4 | Temozolomide (Temodar)FDA LinkGeneric
10/2012
-
01/2005 |
3 | Melanocyte-Stimulating Hormones (MSH)IBA
01/2022
-
11/2019 |
3 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2022
-
01/2020 |
3 | cobimetinibIBA
01/2020
-
08/2014 |
3 | LigandsIBA
01/2019
-
08/2014 |
3 | SurvivinIBA
05/2015
-
04/2009 |
3 | Allovectin-7IBA
01/2011
-
12/2006 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
01/2010
-
06/2009 |
2 | AlbuminsIBA
02/2022
-
01/2010 |
2 | Chelating AgentsIBA
12/2020
-
01/2020 |
2 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
12/2020
-
01/2020 |
2 | RNA (Ribonucleic Acid)IBA
07/2020
-
01/2007 |
2 | Interleukin-8 (Interleukin 8)IBA
01/2019
-
10/2012 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019
-
11/2008 |
2 | Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2018
-
10/2012 |
2 | Messenger RNA (mRNA)IBA
01/2018
-
11/2005 |
2 | sepantroniumIBA
05/2015
-
02/2011 |
2 | Biomarkers (Surrogate Marker)IBA
10/2012
-
04/2010 |
2 | Small Interfering RNA (siRNA)IBA
10/2012
-
02/2012 |
2 | HLA-A*02:01 antigenIBA
12/2011
-
08/2010 |
2 | Protein Subunit VaccinesIBA
06/2011
-
08/2010 |
2 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2010
-
11/2005 |
2 | Sorafenib (BAY 43-9006)FDA Link
06/2009
-
05/2008 |
2 | Transforming Growth Factor beta (TGF-beta)IBA
06/2009
-
10/2007 |
2 | phosphomannopentaose sulfateIBA
11/2008
-
02/2008 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2022 |
1 | Ethylene Glycol (Monoethylene Glycol)IBA
01/2022 |
1 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2022 |
1 | Chemokine CXCL10IBA
12/2021 |
1 | Toll-Like Receptor 9IBA
12/2021 |
1 | HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 |
1 | HLA-A Antigens (HLA-A)IBA
01/2021 |
1 | (2-boronoethyl)-cysteineIBA
01/2021 |
1 | ArginaseIBA
01/2021 |
1 | Interferon-gamma (Interferon, gamma)IBA
01/2021 |
1 | phenylalanylarginineIBA
12/2020 |
1 | MetalsIBA
01/2020 |
1 | GSK2141795IBA
01/2020 |
1 | Interleukin-6 (Interleukin 6)IBA
01/2019 |
1 | SteroidsIBA
01/2019 |
1 | atezolizumabIBA
01/2019 |
1 | CytokinesIBA
01/2019 |
1 | Radioisotopes (Radionuclides)IBA
11/2018 |